Daniel Grandersoneditorial@labpulse.comBusiness InsightsIndia IVD market sales rose to $1.4B in 2022: Kalorama InformationAccording to Kalorama's forecasts, India’s IVD market will increase at a compound annual growth rate (CAGR) of 2.4% from 2022 to 2027.April 26, 2023Business InsightsMexico IVD sales reach $794M: Kalorama InformationImmunoassays are Mexico’s leading IVD segment, followed by point-of-care and microbiology/molecular. Other POC, other molecular, and flow cytometry will be key segments to watch in coming years.April 11, 2023Business InsightsChina worth watching in $3.95B world market for molecular POC tests: Kalorama InformationCentral and provincial governments have played a significant role in the expansion of the POC testing market in China.February 22, 2023Emergency Use AuthorizationCOVID-19 tests attempt to prove at-home testing concept can workThese COVID-19 tests were granted separate emergency use authorizations (EUAs) from the U.S. Food and Drug Administration (FDA) earlier in 2021 and all require nasal swab specimens from patients.August 22, 2021Page 1 of 1Top StoriesCancerInvivoscribe, Complete Genomics partner to develop NGS tests for cancer research, detectionUnder the terms of the deal, Invivoscribe will be responsible for the development of biomarker tests, including test controls and associated bioinformatics software. The tests will run on Complete Genomics' NGS platforms.Regulatory ApprovalSeegene obtains IVDR certification for 30 diagnostic assaysPolicy and RegulationAdvocacy groups in letter urge FDA to develop regulations for lab-developed testsCollaborationNucleai, Adlai Nortye collaborate on biomarkers for clinical trialsSponsor ContentVisit our Molecular Diagnostics Community
